title: Chfr is required for tumor suppression and Aurora A regulation.
abstract: Tumorigenesis is a consequence of loss of tumor suppressors and activation of oncogenes. Expression of the mitotic checkpoint protein Chfr is lost in 20-50% of primary tumors and tumor cell lines. To explore whether downregulation of Chfr contributes directly to tumorigenesis, we generated Chfr knockout mice. Chfr-deficient mice are cancer-prone, develop spontaneous tumors and have increased skin tumor incidence after treatment with dimethylbenz(a)anthracene. Chfr deficiency leads to chromosomal instability in embryonic fibroblasts and regulates the mitotic kinase Aurora A, which is frequently upregulated in a variety of tumors. Chfr physically interacts with Aurora A and ubiquitinates Aurora A both in vitro and in vivo. Collectively, our data suggest that Chfr is a tumor suppressor and ensures chromosomal stability by controlling the expression levels of key mitotic proteins such as Aurora A.
authors.affiliation: Department of Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Yu
authors.forename: Katherine
authors.initials: K
authors.lastname: Minter-Dykhouse
authors.forename: Liviu
authors.initials: L
authors.lastname: Malureanu
authors.forename: Wei-Meng
authors.initials: WM
authors.lastname: Zhao
authors.forename: Dongwei
authors.initials: D
authors.lastname: Zhang
authors.forename: Carolin J
authors.initials: CJ
authors.lastname: Merkle
authors.forename: Irene M
authors.initials: IM
authors.lastname: Ward
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Saya
authors.forename: Guowei
authors.initials: G
authors.lastname: Fang
authors.forename: Jan
authors.initials: J
authors.lastname: van Deursen
authors.forename: Junjie
authors.initials: J
authors.lastname: Chen
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000633:toxicity; D000818:Animals; D064096:Aurora Kinase A; D064127:Aurora Kinases; D002273:Carcinogens / Q000633:toxicity; D018797:Cell Cycle Proteins / Q000235:genetics / Q000502:physiology*; D043171:Chromosomal Instability; D004622:Embryo, Mammalian / Q000166:cytology / Q000201:enzymology; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D015972:Gene Expression Regulation, Neoplastic; D018390:Gene Targeting; D016147:Genes, Tumor Suppressor / Q000502:physiology*; D006579:Heterozygote; D006720:Homozygote; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008938:Mitosis / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology*; D000075223:Poly-ADP-Ribose Binding Proteins; D011494:Protein Kinases / Q000235:genetics / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases; D012878:Skin Neoplasms / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology; D025801:Ubiquitin / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases; D029867:Xenopus Proteins
chemical_list: D002273:Carcinogens; D018797:Cell Cycle Proteins; D009363:Neoplasm Proteins; D000075223:Poly-ADP-Ribose Binding Proteins; D025801:Ubiquitin; D029867:Xenopus Proteins; D015127:9,10-Dimethyl-1,2-benzanthracene; C412002:CHFR protein, human; D044767:Ubiquitin-Protein Ligases; D011494:Protein Kinases; C112134:AURKA protein, Xenopus; C576918:Aurka protein, mouse; D064096:Aurora Kinase A; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases